Immunoglobulin superfamily of proteins, CTLA-4 and PD-1, may generate treatments for RA, SLE
New Therapeutics for Osteoarthritis May Be in Sight
Overview of OA pathogenesis, recent discoveries suggest new treatment strategies are possible
The ACR Recommends Cautious Approach as Biosimilars Enter U.S. Market
With the U.S. FDA’s first approval of a biosimilar drug earlier this month, rheumatologists stress the need to ensure safety, efficacy of such drugs in treating rheumatic diseases
Infliximab, Tocilizumab Can Help in Large Vessel Vasculitis
Case studies show some patients with LVV can achieve remission after treatment with biological agents
Patient’s Journey with Rheumatoid Arthritis Redefines ‘Treat to Target’
Rheumatologist Richard Brasington, MD, says patient John Reigstad’s active participation in treatment decisions shows how much improving quality of life matters
2014 ACR/ARHP Annual Meeting: Rheumatoid Arthritis Management Treatment Recommendations
The ACR shares highlights of in-development guidelines for RA combination strategies, live vaccines and biologics
Chronic Osteoarthritis Management Initiative Calls for Better OA Screening, Treatment
COAMI work group advocates to make early detection, intervention and comprehensive care models integral to medical care
Seizures in Lupus
Case report highlights important twist to differential diagnosis of neuropsychiatric lupus
Skin Disease in Rheumatology Patients Should Prompt Collaboration with Dermatologists
Patients with conditions that don’t resolve with topical steroids are signal for referral
Generic Colchicine Approved for Gout Prophylaxis
The cost for therapeautic gout treatment may soon go down, thanks to a recent court ruling
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 41
- Next Page »